Developing novel blood-stage malaria vaccines
<p>Natural exposure to Plasmodium falciparum’s asexual blood-stage results in protection against severe disease, but no vaccine using the widely-studied blood-stage antigens apical membrane antigen 1 (AMA1) or merozoite surface protein 1 (MSP1) has proven convincingly protective in clinical tr...
Príomhchruthaitheoir: | Douglas, AD |
---|---|
Rannpháirtithe: | Draper, SJ |
Formáid: | Tráchtas |
Teanga: | English |
Foilsithe / Cruthaithe: |
2015
|
Ábhair: |
Míreanna comhchosúla
Míreanna comhchosúla
-
Pre-clinical development of viral vectored transmission-blocking malaria vaccines
de réir: Kapulu, MC
Foilsithe / Cruthaithe: (2014) -
Enhancing the efficacy of viral vector blood-stage malaria vaccines
de réir: Forbes, E
Foilsithe / Cruthaithe: (2011) -
Analysis of b cell responses to blood-stage malaria antigens in humans following immunization with candidate vaccines and controlled human malaria infection
de réir: Elias, SC
Foilsithe / Cruthaithe: (2014) -
Liver-stage vaccines for malaria
de réir: Longley, RJ
Foilsithe / Cruthaithe: (2013) -
Malaria pre-erythrocytic stage vaccines: targeting antigen combinations
de réir: Bauza, K
Foilsithe / Cruthaithe: (2012)